VolitionRx (VNRX) Institutional Ownership → Don’t expose yourself to stocks during the week (From DTI) (Ad) Free VNRX Stock Alerts $0.77 -0.03 (-3.75%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for VolitionRx (NYSE:VNRX)CurrentInstitutional OwnershipPercentage8.09%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$105.43KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$31.87K Ad DTIDon’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. VolitionRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2024 Silverberg Bernstein Capital Management LLC147,038$105K0.1%N/A0.187% 11/14/2023 Lagoda Investment Management L.P.3,882,850$2.68M1.8%-1.2%4.969% (Data available from 1/1/2016 forward) VNRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VNRX shares? During the previous two years, the following institutional investors and hedge funds held shares of VolitionRx shares: Lagoda Investment Management L.P. ($2.68M), Silverberg Bernstein Capital Management LLC ($105K).Learn more on VNRX's institutional investors. What percentage of VolitionRx stock is owned by institutional investors? 8.09% of VolitionRx stock is owned by institutional investors. Learn more on VNRX's institutional investor holdings. Which institutional investors have been buying VolitionRx stock? The following institutional investors have purchased VolitionRx stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($147.04K). How much institutional buying is happening at VolitionRx? Institutional investors have bought a total of 147,038 shares in the last 24 months. This purchase volume represents approximately $105.43K in transactions. Which VolitionRx major shareholders have been selling company stock? The following institutional investors have sold VolitionRx stock in the last 24 months: Lagoda Investment Management L.P. ($46.26K). How much institutional selling is happening at VolitionRx? Institutional investors have sold a total of 46,260 shares in the last 24 months. This volume of shares sold represents approximately $31.87K in transactions. Related Companies: TKNO Major Shareholders ABIO Major Shareholders ICCC Major Shareholders AWH Major Shareholders OCX Major Shareholders CDIO Major Shareholders ACHV Major Shareholders PTWO Major Shareholders TOI Major Shareholders RLYB Major Shareholders This page (NYSE:VNRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist My Default Watchlist Adding VolitionRx Limited You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.